NTRK2 and neoplasm: Elevation of BDNF has been associated with poor prognosis in neuroblastoma [52] and has been shown to increase tumor cell viability via BDNF-mediated activation of tropomyosin receptor kinase B (TrkB) signaling in gynecologic cancer cells [53].